N/A Completed N=42 Randomized Single-blind Treatment

Natriuretic Brain Pro-peptid Changes in Patients With Chronic Heart Failure Within a Cardiac Rehabilitation Program

Heart Failure

Source: ClinicalTrials.gov NCT02087670 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Aug 2014

Primary outcomePrimary: Natriuretic Brain Pro-peptid — 312; 200 pg/ml

Summary

Evaluate pro-BNP levels, oxygen consumption, functional class, and quality of life in patients with chronic heart failure after participating in an exercise program and compare them baseline and 2 months, with another group who underwent an educational program.

Outcome Measures

Outcome	Result	p-value
PRIMARY Natriuretic Brain Pro-peptid	312; 200	—
SECONDARY Oxygen Consumption	831; 919	—

Eligibility Criteria

Inclusion Criteria

Patients older than 18 years, diagnosed with heart failure (NYHA) II-IV for more than six months

Exclusion Criteria

patients with NYHA functional class I, who had attended a cardiac rehabilitation program previously, patients with decompensated diabetes mellitus, hypertension difficult to control, ischemic heart disease in the last month, prior pulmonary embolism, chronic obstructive pulmonary disease, restrictive lung disease , aortic stenosis, new episode of atrial fibrillation and musculoskeletal diseases that limit the performance of physical activity

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02087670). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.